LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) and its use as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

21-norrapamycin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

21-norvitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-substituted progesterone derivatives as new...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-substituted progesterone derivatives as new...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

21-substituted progesterone derivatives as new...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

21-Substituted steroid compound

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

22-en-25-oxa derivatives in the vitamin D series, process for th

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

22-thio vitamin D derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

22R-hydroxycholesta-8, 14-diene derivatives for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

22s-hydroxycholesta-8, 14-diene derivatives with meiosis...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

23-imino derivatives of 23-keto compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

23-Imino derivatives of LL-F28249 compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

23-nor-23-oxa avermectin analogs are active anthelmintic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

23-nor-23-thia avermectin analogs are active anthelmintic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

23-oxa-derivatives in the vitamin D series, process for their pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

23-Oxo (keto) and 23-imino derivatives of mono- and diepoxy LL-F